©istock.com/Andrea Obzerova
Unsere KompetenzInterdisziplinäre Diagnostik
Know how bei der Analyse von Erbmaterial.
Zum Wohle von Patientinnen und Patienten.

Klinische FragestellungHirnfehlbildungen, kongenital; Differentialdiagnose

Zusammenfassung

Kurzinformation

Ein kuratiertes panel mit 78 Genen zur umfassenden Untersuchung von praktisch allen bekannten genetisch bedingten angeborenen Hirnfehlbildungen

ID
HP1100
Anzahl Loci
Loci-TypAnzahl
Gen82
Akkreditierte Untersuchung
Untersuchte Sequenzlänge
35,9 kb (Core-/Core-canditate-Gene)
222,5 kb (Erweitertes Panel: inkl. additional genes)
Analyse-Dauer
auf Anfrage
Untersuchungsmaterial
  • EDTA-Blut (3-5 ml)
Diagnostische Hinweise

NGS +

 

Locipanel

Gen

NameExon-Länge (bp)OMIM-GReferenz-Seq.Erbgang
ACTB1128NM_001101.5AD
AKT31440NM_005465.7AD
DCX1083NM_178153.3XL
DISP14575NM_032890.5AD
KIF5C2874NM_004522.3AD
MTOR7650NM_004958.4AD
NEDD4L2868NM_015277.6AD
PIK3CA3207NM_006218.4AD
PIK3R22187NM_005027.4AD
PROK2390NM_001126128.2AR
PROKR21155NM_144773.4AD, AR
TUBB2B1338NM_178012.5AD
TUBG11356NM_001070.5AD
WDR624572NM_001083961.2AR
ACTG11128NM_001614.5AD
ADGRG12064NM_005682.7AR
AKT11443NM_005163.2n.k.
ARFGEF25358NM_006420.3AR
ASPM10434NM_018136.5AR
B3GALNT21503NM_152490.5AR
CCND2870NM_001759.4AD
CDK134711NM_003718.5AD
CDON3795NM_016952.5AD
COL3A14401NM_000090.4AD, AR
CRPPA1356NM_001101426.4AR
CSNK2A11545NM_001895.4AD
DAG12688NM_004393.6AR
DHCR71428NM_001360.3AR
DYNC1H113941NM_001376.5AD
EMX2759NM_004098.4AD
FGF8735NM_033163.5AD
FGFR12469NM_023110.3AD
FIG42724NM_014845.6AR
FKRP1488NM_024301.5AR
FKTN1386NM_001079802.2AR
FLNA7920NM_001456.4XL
GLI24761NM_005270.5AD
GPSM22055NM_013296.5AR
KATNB11968NM_005886.3AR
KIF2A2235NM_001098511.3AD
KIFBP1866NM_015634.4AR
LAMB15361NM_002291.3AR
LAMC34728NM_006059.4AR
LARGE12271NM_004737.7AR
MACF116293NM_012090.5AD
NDE11008NM_001143979.2AR
OCLN1569NM_002538.4AR
OSGEP1019NM_017807.4AR
PAFAH1B11233NM_000430.4AD
PEX13852NM_000466.3AR
PEX101041NM_153818.2AR
PEX11B780NM_003846.3AR
PEX121080NM_000286.3AR
PEX131212NM_002618.4AR
PEX141134NM_004565.3AR
PEX161011NM_004813.4AR
PEX19900NM_002857.4AR
PEX2918NM_000318.3AR
PEX26918NM_017929.6AR
PEX31122NM_003630.3AR
PEX51920NM_001131025.2AR
PEX62943NM_000287.4AR
PEX7972NM_000288.4AR
PHGDH1602NM_006623.4AR
POMGNT11983NM_017739.4AR
POMGNT21743NM_032806.6AR
POMT12244NM_007171.4AR
POMT22253NM_013382.7AR
PTCH14344NM_000264.5AD
PTEN1212NM_000314.8AD
RELN10383NM_005045.4AR, AD
RTTN6681NM_173630.4AR
RXYLT11355NM_014254.3AR
SHH1389NM_000193.4AD
SIX3999NM_005413.4AD
SMO2364NM_005631.5AD
TGIF1819NM_173208.3AD
TUBA1A1356NM_006009.4AD
TUBB1335NM_178014.4AD
TUBB2A1338NM_001069.3AD
TUBB31353NM_006086.4AD
ZIC21599NM_007129.5AD

Infos zur Erkrankung

Synonyme
  • Alias: Zerebrale Malformationen, kongenital
  • Allelic: Amyotrophic lateral sclerosis 11 (FIG4)
  • Allelic: Basal cell carcinoma, somatic (PTCH1)
  • Allelic: Basal cell nevus syndrome (PTCH1)
  • Allelic: CLAPO syndrome, somatic (PIK3CA)
  • Allelic: CLOVE syndrome, somatic (PIK3CA)
  • Allelic: Cardiac valvular dysplasia, XL (FLNA)
  • Allelic: Cardiomyopathy, dilated, 1X (FKTN)
  • Allelic: Charcot-Marie-Tooth disease, axonal, type 20 (DYNC1H1)
  • Allelic: Charcot-Marie-Tooth disease, type 4J (FIG4)
  • Allelic: Colorectal cancer, somatic (PIK3CA)
  • Allelic: Congenital short bowel syndrome (FLNA)
  • Allelic: Cowden syndrome 1 (PTEN)
  • Allelic: Cowden syndrome 5 (PIK3CA)
  • Allelic: Cowden syndrome 6 (AKT)
  • Allelic: Curry-Jones syndrome, somatic mosaic (SMO)
  • Allelic: Deafness, AD 20/26 (ACTG1)
  • Allelic: Dystonia, juvenile-onset (ACTB)
  • Allelic: Epilepsy, familial temporal lobe, 7 (RELN)
  • Allelic: Fibrosis of extraocular muscles, congenital, 3A (TUBB3)
  • Allelic: Glioma susceptibility 2 (PTEN)
  • Allelic: Heimler syndrome 1 (PEX1)
  • Allelic: Heimler syndrome 2 (PEX6)
  • Allelic: Lhermitte-Duclos syndrome (PTEN)
  • Allelic: Melnick-Needles syndrome (FLNA)
  • Allelic: Meningioma (PTEN)
  • Allelic: Microphthalmia with coloboma 5 (SHH)
  • Allelic: Muscular dystrophy-dystroglycanopathy, limb-girdle, type C, 1 (POMT1)
  • Allelic: Muscular dystrophy-dystroglycanopathy, limb-girdle, type C, 12 (POMK)
  • Allelic: Muscular dystrophy-dystroglycanopathy, limb-girdle, type C, 3 (POMGNT1)
  • Allelic: Muscular dystrophy-dystroglycanopathy, limb-girdle, type C, 4 (FKTN)
  • Allelic: Muscular dystrophy-dystroglycanopathy, limb-girdle, type C, 5 (FKRP)
  • Allelic: Muscular dystrophy-dystroglycanopathy, limb-girdle, type C, 7 (ISPD)
  • Allelic: Muscular dystrophy-dystroglycanopathy, limb-girdle, type C, 8 (POMGNT2)
  • Allelic: Muscular dystrophy-dystroglycanopathy, limb-girdle, type C, 9 (DAG1)
  • Allelic: Retinitis pigmentosa 76 (POMGNT1)
  • Allelic: Single median maxillary central incisor (SHH)
  • Allelic: Spastic paraplegia 84, AR (PI4KA)
  • Allelic: Spinal muscular atrophy, lower extremity-predominant 1, AD (DYNC1H1)
  • Allelic: Symmetric circumferential skin creases, congenital, 1 (TUBB)
  • Adams-Oliver syndrome 2 (DOCK6)
  • Arthrogryposis [panelapp. MONDO:0008779] (KIF21A)
  • Asparagine synthetase deficiency (ASNS)
  • Baraitser-Winter syndrome 1 (ACTB)
  • Baraitser-Winter syndrome 2 (ACTG1)
  • Brain malformations +/- urinary tract defects (NFIA)
  • CHILD syndrome (NSDHL)
  • CK syndrome (NSDHL)
  • Chudley-McCullough syndrome (GPSM2)
  • Congenital heart defects, dysmorphic facial features, intellectual developmental disorder (CDK13)
  • Congenital hyperinsulinism [panelapp] (FOXA2)
  • Congenital hypopituitarism [panelapp] (FOXA2)
  • Cortical dysplasia, complex, with other brain malformations 1 (TUBB3)
  • Cortical dysplasia, complex, with other brain malformations 10 (APC2)
  • Cortical dysplasia, complex, with other brain malformations 2 (KIF5C)
  • Cortical dysplasia, complex, with other brain malformations 3 (KIF2A)
  • Cortical dysplasia, complex, with other brain malformations 4 (TUBG1)
  • Cortical dysplasia, complex, with other brain malformations 5 (TUBB2A)
  • Cortical dysplasia, complex, with other brain malformations 6 (TUBB)
  • Cortical dysplasia, complex, with other brain malformations 7 (TUBB2B)
  • Cortical malformations, occipital (LAMC3)
  • Culler-Jones syndrome (GLI2)
  • Developmental + epileptic encephalopathy 1 (ARX)
  • Ehlers-Danlos syndrome, vascular type (COL3A1)
  • Encephalocraniocutaneous lipomatosis, somatic mosaic (FGFR1)
  • FG syndrome 2 (FLNA)
  • Fetal akinesia (KIF21A)
  • Fibrosis of extraocular muscles, congenital, 1 (KIF21A)
  • Fibrosis of extraocular muscles, congenital, 3B (KIF21A)
  • Focal cortical dysplasia, type II, somatic (MTOR)
  • Frontometaphyseal dysplasia 1 (FLNA)
  • Galloway-Mowat syndrome 3 (OSGEP)
  • Gastrointestinal defects and immunodeficiency syndrome 2 (PI4KA)
  • Gaze palsy, familial horizontal, with progressive scoliosis, 1 (ROBO3)
  • Gaze palsy, familial horizontal, with progressive scoliosis, 2 (DCC)
  • Goldberg-Shprintzen megacolon syndrome (KIF1BP)
  • Hartsfield syndrome (FGFR1)
  • Heterotopia, periventricular, 1 (FLNA)
  • Holoprosencephaly (DISP1, FGF8)
  • Holoprosencephaly 11 (CDON)
  • Holoprosencephaly 2 (SIX3)
  • Holoprosencephaly 3 (SHH)
  • Holoprosencephaly 4 (TGIF1)
  • Holoprosencephaly 5 (ZIC2)
  • Holoprosencephaly 7 (PTCH1)
  • Holoprosencephaly 9 (GLI2)
  • Hydranencephaly with abnormal genitalia (ARX)
  • Hypogonadotropic hypogonadism 2 +/- anosmia (FGFR1)
  • Hypogonadotropic hypogonadism 3 +/- anosmia (PROKR2)
  • Hypogonadotropic hypogonadism 4 +/- anosmia (PROK2)
  • Hypogonadotropic hypogonadism 6 +/- anosmia (FGF8)
  • Hypopituitarism, craniofacial + endoderm-derived organ abnormalities [panelapp] (FOXA2)
  • Intellectual developmental disorder, AR 34, with variant lissencephaly (CRADD)
  • Intellectual developmental disorder, AR 74 (APC2)
  • Joubert syndrome 3 (AHI1)
  • Lissencephaly 1 (PAFAH1B1)
  • Lissencephaly 2 [Norman-Roberts type] (RELN)
  • Lissencephaly 3 (TUBA1A)
  • Lissencephaly 4 [with microcephaly] (NDE1)
  • Lissencephaly 5 (LAMB1)
  • Lissencephaly 6, with microcephaly (KATNB1)
  • Lissencephaly 9 with complex brainstem malformation (MACF1)
  • Lissencephaly, XL 2 (ARX)
  • Macrocephaly/autism syndrome (PTEN)
  • Martsolf syndrome 2 (RAB3GAP1)
  • Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic (PIK3A)
  • Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1 (PIK3R2)
  • Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2 (AKT3)
  • Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3 (CCND2)
  • Mental retardation, AD 13 (DYNC1H1)
  • Mental retardation, XL 29 + others (ARX)
  • Microcephaly 17, primary, AR (CIT)
  • Microcephaly 2, primary, AR, with/-out cortical malformations (WDR62)
  • Microcephaly 3, primary, AR (CDK5RAP2)
  • Microcephaly 5, primary, AR (ASPM)
  • Microcephaly 7, primary, AR (STIL)
  • Microcephaly, epilepsy, and diabetes syndrome (IER3IP1)
  • Microcephaly, progressive, seizures, cerebral + cerebellar atrophy (QARS1)
  • Microcephaly, short stature + polymicrogyria with seizures (RTTN)
  • Microhydranencephaly (NDE1)
  • Mirror movements 1 and/or agenesis of the corpus callosum (DCC)
  • Multinucleated neurons, anhydramnios, renal dyspl., cerebellar hypopl., hydranencephaly (CEP55)
  • Multiple congenital anomalies-hypotonia-seizures syndrome 2 (PIGA)
  • Muscular dystrophy-dystroglycanopathy, cong. with brain + eye anomalies, type A, 1 (POMT1)
  • Muscular dystrophy-dystroglycanopathy, cong. with brain + eye anomalies, type A, 10 (TMEM5)
  • Muscular dystrophy-dystroglycanopathy, cong. with brain + eye anomalies, type A, 11 (B3GALNT2)
  • Muscular dystrophy-dystroglycanopathy, cong. with brain + eye anomalies, type A, 12 (POMK)
  • Muscular dystrophy-dystroglycanopathy, cong. with brain + eye anomalies, type A, 13 (B4GAT1)
  • Muscular dystrophy-dystroglycanopathy, cong. with brain + eye anomalies, type A, 3 (POMGNT1)
  • Muscular dystrophy-dystroglycanopathy, cong. with brain + eye anomalies, type A, 4 (FKTN)
  • Muscular dystrophy-dystroglycanopathy, cong. with brain + eye anomalies, type A, 5 (FKRP)
  • Muscular dystrophy-dystroglycanopathy, cong. with brain + eye anomalies, type A, 6 (LARGE1)
  • Muscular dystrophy-dystroglycanopathy, cong. with brain + eye anomalies, type A, 7 (ISPD)
  • Muscular dystrophy-dystroglycanopathy, cong. with brain + eye anomalies, type A, 8 (POMGNT2)
  • Muscular dystrophy-dystroglycanopathy, cong. with brain + eye anomalies, type A, 9 (DAG1)
  • Muscular dystrophy-dystroglycanopathy, cong. with mental retardation, type B, 1 (POMT1)
  • Muscular dystrophy-dystroglycanopathy, cong. with mental retardation, type B, 3 (POMGNT1)
  • Muscular dystrophy-dystroglycanopathy, cong. with mental retardation, type B, 6 (LARGE1)
  • Muscular dystrophy-dystroglycanopathy, cong. with/-out mental retardation, type B, 5 (FKRP)
  • Muscular dystrophy-dystroglycanopathy, cong. without mental retardation, type B, 4 (FKTN)
  • Neu-Laxova syndrome 1 (PHGDH)
  • Neurodevelopmental disorder with epilepsy + hemochromatosis )PIGA)
  • Neurodevelopmental disorder with microcephaly, cortical malformations, spasticity (TMX2)
  • Okur-Chung neurodevelopmental syndrome (CSNK2A1)
  • Orofaciodigital syndrome XIV (C2CD3)
  • Pallister-Hall-like syndrome (SMO)
  • Partington syndrome (ARX)
  • Periventricular heterotopia with microcephaly (ARFGEF2)
  • Periventricular nodular heterotopia 7 (NEDD4L)
  • Peroxisome biogenesis disorder 10A [Zellweger] (PEX3)
  • Peroxisome biogenesis disorder 10B (PEX3)
  • Peroxisome biogenesis disorder 11A [Zellweger] (PEX13)
  • Peroxisome biogenesis disorder 11B (PEX13)
  • Peroxisome biogenesis disorder 12A [Zellweger] (PEX19)
  • Peroxisome biogenesis disorder 13A [Zellweger] (PEX14)
  • Peroxisome biogenesis disorder 14B (PEX11B)
  • Peroxisome biogenesis disorder 1A [Zellweger] (PEX1)
  • Peroxisome biogenesis disorder 1B [NALD/IRD] (PEX1)
  • Peroxisome biogenesis disorder 2A [Zellweger] (PEX5)
  • Peroxisome biogenesis disorder 2B (PEX5)
  • Peroxisome biogenesis disorder 3A [Zellweger] (PEX12)
  • Peroxisome biogenesis disorder 3B (PEX12)
  • Peroxisome biogenesis disorder 4A [Zellweger] (PEX6)
  • Peroxisome biogenesis disorder 4B (PEX6)
  • Peroxisome biogenesis disorder 5A [Zellweger] (PEX2)
  • Peroxisome biogenesis disorder 5B (PEX2)
  • Peroxisome biogenesis disorder 6A [Zellweger] (PEX10)
  • Peroxisome biogenesis disorder 6B (PEX10)
  • Peroxisome biogenesis disorder 7A [Zellweger] (PEX26)
  • Peroxisome biogenesis disorder 7B (PEX26)
  • Peroxisome biogenesis disorder 8A [Zellweger] (PEX16)
  • Peroxisome biogenesis disorder 8B (PEX16)
  • Peroxisome biogenesis disorder 9B (PEX7)
  • Phosphoglycerate dehydrogenase deficiency (PHGDH)
  • Polymicrogyria +/- vascular-type EDS (COL3A1)
  • Polymicrogyria, bilateral frontoparietal (ADGRG1)
  • Polymicrogyria, bilateral perisylvian (ADGRG1)
  • Polymicrogyria, bilateral temporooccipital (FIG4)
  • Polymicrogyria, perisylvian, with cerebellar hypoplasia + arthrogryposis (PI4KA)
  • Proteus syndrome, somatic (AKT)
  • Proud syndrome (ARX)
  • Pseudo-TORCH syndrome 1 (OCLN)
  • Pseudo-TORCH syndrome 2 (USP18)
  • Rhizomelic chondrodysplasia punctata, type 1 (PEX7)
  • Rhizomelic chondrodysplasia punctata, type 5 (PEX5)
  • Schizencephaly (EMX2, SHH, SIX3)
  • Severe combined immunodeficiency, microcephaly, growth retardation, radiation sensitive (NHEJ1)
  • Smith-Kingsmore syndrome (MTOR)
  • Smith-Lemli-Opitz syndrome (DHCR7)
  • Subcortical laminal heterotopia, XL (DCX)
  • Subcortical laminar heterotopia (PAFAH1B1)
  • Vici syndrome (EPG5)
  • Warburg micro syndrome 1 (RAB3GAP1)
  • Yunis-Varon syndrome (FIG4)
Erbgänge, Vererbungsmuster etc.
  • AD
  • AR
  • XL
  • n.k.
OMIM-Ps
  • Multiple OMIM-Ps
ICD10 Code

Bioinformatik und klinische Interpretation

Kein Text hinterlegt